Search research articles
Contact Us
Filters
Showing results (111-120 of 144) with videos related to
Page
of 15
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
January 11, 2014
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles
Daniel R Dietrich, Sonja von Aulock, Hans Marquardt, et al.
Toxicology Letters
|
January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Chemico-Biological Interactions
|
May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Environmental Toxicology and Pharmacology
|
May 12, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology
|
June 10, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Lupus
|
February 21, 2015
Lupus in Latin-American patients: lessons from the GLADEL cohort
G J Pons-Estel, L J Catoggio, M H Cardiel, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 144) with videos related to
Sort By:
Page
of 15
Toxicon : Official Journal of the International Society on Toxinology
|
January 11, 2014
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles
Daniel R Dietrich, Sonja von Aulock, Hans Marquardt, et al.
Toxicology Letters
|
January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology
Frank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
Chemico-Biological Interactions
|
May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Environmental Toxicology and Pharmacology
|
May 12, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Journal of Toxicology and Environmental Health. Part A
|
June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology
|
June 10, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Lupus
|
February 21, 2015
Lupus in Latin-American patients: lessons from the GLADEL cohort
G J Pons-Estel, L J Catoggio, M H Cardiel, et al.
Page
of 15